Collaborators.
Our research on Acute Myeloid Leukaemia and Multiple Myeloma has led to collaborations with several leading researchers in these fields. In particular, the unique work focusing on modelling and therapeutically targeting the bone marrow microenvironment in AML and MM, have led to productive partnerships with many leading local, national and international academic and clinical external and industrial collaborators.
Research Topic
Development of a novel platform lipid nanoparticle (LNP) system to induce tailored immune responses for therapeutic benefit.
Research Topic
Macrophage-driven therapy resistance in AML.
Research Topic
Role of HSP70 in the pathophysiology of AML.
Research Topic
Macrophage driven therapy resistance in AML
Research Topic
Macrophage driven therapy resistance in AML
Research Topic
Fibroblast-mediated therapy resistance in AML.
Collaborators
Name
Institution
University of Glasgow
Cornell University
Research Topic
Macrophage-driven therapy resistance in AML
Collaborators
Name
Institution
Cornell University
University of Glasgow
Research Topic
Macrophage-mediated therapy resistance in MM
Research Topic
Fibroblast-driven drug resistance in AML.
Collaborators
Name
Institution
University of Glasgow
Cornell University
Research Topic
Developing a novel multi-targeting therapeutic antibody for MM
Collaborators
Name
Drs Matthew Powell & Ross Henderson
Institution
University of Strathclyde
University of Strathclyde
The Antibody Company
The Beatson West of Scotland Cancer Centre.
University of Edinburgh
University of Edinburgh
Research Topic
Therapeutic Potential of CBP/P300 and STAT3 Protein Degraders in MM.